Company Team
The company has more than 500 employees, including 1 Changjiang Scholar, 6 professors and doctoral supervisors, and 30 PhD supervisors; more than 60% of the employees have a master's degree or above.
Scientific Advisory Committee
Technology Management Committee
Cheng Changmei Professor, PhD supervisor
Chemical synthesis consultant
Strategic Partners
Professor, Doctoral Supervisor, Department of Chemistry, University of Tokyo, Tsinghua University, Japan
Famous domestic nucleic acid synthesis expert
The first synthetic anti-SARS virus drug in China
Research on antiviral (HIV and HBV as the focus) and antitumor activity centered on the synthesis of new nucleosides and their oligonucleotides.
Research on the origin of nucleic acid and genetic code centered on the synthesis and self-polymerization of thionucleosides.
Research on anti-AIDS drugs based on synthetic thiopolysaccharide compounds.
Long Zechun Professor, PhD supervisor
Innovative formulation consultant
Doctor of Pharmacy, University of South Carolina
Former Dean and Doctoral Supervisor of the School of Pharmacy, Yeongnam University, South Korea
Served as Chairman of the Korean Society of Pharmaceutical Science and Technology, Chairman of the Asian Federation of Pharmaceutical Sciences (AFPS), Chairman of the AFPS Conference Organizing Committee
Published more than 250 SCI papers and several books
Alan
Chief Consultant of International Cooperation
PhD in Chemistry from Oxford University, PhD in Organic Chemistry from Columbia
Good at basic research, strategic consulting, executive operations and investment management capital markets.
He was engaged in chemical research at Merck in the United States, and later joined McKinsey & Company, responsible for global healthcare investment and overall industrial investment research. Later founded Chiral Quest, Inc. as the first CEO and CFO.
Sundus Tewfik
International Cooperative New Drug Evaluation Consultant
Holds a master's degree in applied microbiology and a doctorate in pharmacology.
Dr. Tewfik adopted a new concept, combining customized functional formulas with standard pharmacological therapies. To
Her current nutritional health research utilizes the application of pharmacology and clinical nutrition in nutritional intervention programs that aim to combat chronic diseases related to immunity, cancer, cardiovascular, and cognitive impairment.
Zhao Kang Professor, PhD supervisor
chief scientist
partner
The first batch of Yangtze River scholars
Former Chief Scientist of Novartis
Columbia University Professor
Chair of the Chemistry Department of the New York Academy of Sciences
Dean of School of Pharmacy, Tianjin University
Won the Outstanding Youth Research Award of the American Chemical Society
American Cancer Society Outstanding Youth Research Award
National Science Foundation Outstanding Young Scientist Award
Zhong Bohua Professor, PhD supervisor
Chief Scientist of Innovative Drug Synthesis
Co-founder
Doctor of Medicinal Chemistry, Postdoctoral Fellow, University of Connecticut
Served as a researcher at the Institute of Toxicology and Medicine of the Academy of Military Medical Sciences
Professor of Shenyang Pharmaceutical University
Member of the National Pharmacopoeia Committee
As the host, he developed 4 national second-class new drugs, 2 of which were the first domestic companies to apply for clinical trials; 1 product was included in the second phase of the national chemical drug development guidelines.
As the first inventor to develop 10 new chemical entity drug candidates
As the first inventor, applied for 66 patents, 39 of which have been authorized; published more than 50 papers
Mei Xingguo Professor, PhD supervisor
Technical Director of Innovative Preparations
Former Director of the Pharmacy Teaching and Research Section of the Academy of Military Medical Sciences, Director of the Six Preparation Offices
Member of the Academic Committee of the State Key Laboratory of Biochemical Engineering, Chinese Academy of Sciences
Member of the Academic Committee of the Ministry of Education and Military Key Laboratory of Intelligent Drug Delivery of Fudan University
Long engaged in the research of sustained and controlled release, liposomes, microsphere preparations and new drug delivery devices
Nie Aihua Professor, PhD supervisor
Synthesis Technical Director
General Manager of Jinan Branch
partner
Doctor of Science, Peking University, Postdoctoral Fellow, Sanford-Burnham Institute of Medical Research, USA
Served as a researcher and doctoral supervisor of the Institute of Toxicology and Drugs of the Academy of Military Medical Sciences
Serving as a member of the editorial board of "Chinese Journal of Medicinal Chemistry" and "Chinese Pharmacy" (English Edition)
Mainly engaged in medicinal chemistry, organic chemistry basic and applied research, the research field involves drug molecular design, drug synthesis and other disciplines.
Published 35 articles related to drug design and synthesis in domestic and foreign journals, and obtained 7 authorized Chinese patents
Zhao Huaiqing Professor, PhD supervisor
Technical Director of Analysis Department
Guiyang Center R&D Management Affairs
partner
Senior Visiting Scholar, Toyama University of Medical and Pharmaceutical Sciences, Japan
Former Professor of Analytical Chemistry and Doctoral Supervisor of Shenyang Pharmaceutical University
Served as Deputy Director of the Basic Department of Shenyang Pharmaceutical University, Secretary of the Party Committee and Deputy Dean of the School of Pharmacy, etc.
Presided over and participated in the national major new drug creation comprehensive platform-preclinical pharmacokinetics technology sub-platform project, the national "Tenth Five-Year Plan" major scientific research project, the National Pharmacopoeia Commission funded project, the National Natural Science Foundation of China
Participated in the compilation of 23 pharmacy planning textbooks for medical colleges and universities across the country, and published more than 110 academic papers in domestic and foreign academic journals.
Yan Yidong PhD, PhD supervisor
Vice President, Director of Preparation Technology
General Manager of Beijing Branch
partner
PhD in Pharmaceutical Preparation, Yeongnam University, Korea
Since 2004, he has been working in Beijing Fukangren Biological Professional Technology Co., Ltd., leading the scientific research team to overcome a number of technical difficulties in preparations, and is responsible for organizing and implementing a number of provincial and municipal scientific research projects
Good at using nanotechnology to improve the bioavailability of drugs and targeted drug delivery, the development, evaluation and application of prodrug technology, and the development and evaluation of new formulations
Lu Dan
Clinical Director
Ten years of experience in drug clinical research and development.
Worked in many multinational pharmaceutical companies and CRO companies, such as Novartis, Quintiles, BeiGene, etc.
He has rich experience in clinical research and development of new drugs and project management, and has participated in the clinical development of innovative drugs in multiple therapeutic fields, such as a variety of tumor drugs PD-1, BTK, KRAS, etc.
